Why the Patent Waiver on COVID-19 Drugs Is Wrong

Friday May 7, 2021 12:30PM CDT


Join Amesh Adalja (Johns Hopkins Center for Health Security), Adam Mossoff (Antonin Scalia Law School, George Mason University) and Gregory Salmieri (Salem Center, University of Texas, Austin) as they make the case that the Biden Administration’s decision to support the proposal to suspend patent protections for all patents and other IP rights on COVID-19 vaccines and drugs is wrong, impractical, and destructive.